Pancreatic Cancer Pipeline Review, 2015 RnRMarketResearch.com Adds “Pancreatic Cancer - Pipeline Review, 2015” which provides an overview of the Pancreatic Cancer. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer diagnostic tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by our team of industry experts. Complete report on 2015 Pipeline Review of “Pancreatic Cancer” addition with 189 market data tables and 4 figures, spread across 107 pages is http://www.rnrmarketresearch.com/pancreatic-cancer-pipeline-review-2015-marketreport.html .
Scope: •
Extensive coverage of the Pancreatic Cancer diagnostic tests under development
•
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
•
The report reviews the major players involved in the development of Pancreatic Cancer diagnostic tests and list all their pipeline projects
•
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
•
The report provides key clinical trial data of ongoing trials specific to pipeline products
•
Recent developments in the segment / industry
Reasons to buy: •
Formulate significant competitor information, analysis, and insights to improve R&D strategies
•
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
•
Identify and understand important and diverse types of Pancreatic Cancer diagnostic tests under development
•
Develop market-entry and market expansion strategies
•
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
•
In-depth analysis of the product's current stage of development, territory and estimated launch date
Request for sample: http://www.rnrmarketresearch.com/contacts/request-sample?rname=424805 . (This is a premium report price at US$4000 for a single user PDF license)
Companies Discussed/Mentioned in this Research: A&G Pharmaceutical Inc., Abcodia Ltd., Acobiom, Andraka Technologies LLC, Applied Proteomics Inc., Asuragen Inc., BioMarker Strategies LLC, Biouniversa s.r.l., Cancer Research Technology Limited, Cellmid Limited, Cepheid, Chronix Biomedical Inc., Cleveland Diagnostics Inc., Clovis Oncology Inc., CompanDX Ltd., Courtagen Life Sciences Inc., CS-Keys Inc., Dartmouth College, Di.V.A.L Toscana srl, Exact Sciences Corporation, GeneFluidics Inc., German Cancer Research Center, GlycoZym, Health Discovery Corporation, Hebrew University of Jerusalem, ImmunoCellular Therapeutics Ltd., Immunomedics Inc., Imperial College London, IV Diagnostics Inc., Matrix-Bio Inc., Mayo Clinic, MDNA Life Sciences Inc., Merrimack Pharmaceuticals, Inc., Metanomics Health GmbH, Milagen Inc., Miraculins Inc., NanoScale Corporation, NatiMab Therapeutics S.r.l., National Cheng-Kung University, Neogenix Oncology, Inc., Onconome Inc., OPKO Health Inc., Oxford Gene Technology, PeriRx LLC, Precision Biologics Inc., Proplex Technologies Llc, Protagen AG, SDIX LLC, Sienna Cancer Diagnostics Ltd, SomaLogic Inc., Source MDx, Stanford University, The Johns Hopkins University, Thomas Jefferson University, US Biomarkers Inc., Viomics Inc., Vitatex Inc. and VolitionRX Ltd.
Explore More Research Report on Surgical Equipment Market. About Us: RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.